Get started
Author

Alex J. Gooding

Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance
2020 · Alex J. Gooding, William P. Schiemann · Molecular Cancer Research · 133
The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence
2017 · Alex J. Gooding, Bing Zhang, et al. · Scientific Reports · 92
PDF
The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
2018 · Alex J. Gooding, Bing Zhang, et al. · Oncogene · 91
SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness
2020 · Nathaniel J Robinson, Chevaun D Morrison-Smith, et al. · Life Science Alliance · 19
PDF
Construction and characterization of a sox9b transgenic reporter line
2014 · Jessica S. Plavicki, Tracie R. Baker, et al. · The International Journal of Developmental Biology · 19
The lncRNA BORG: a novel inducer of TNBC metastasis, chemoresistance, and disease recurrence
2019 · Alex J. Gooding, Kimberly A. Parker, et al. · Journal of Cancer Metastasis and Treatment · 13
PDF
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells
2016 · Alex J. Gooding, William P. Schiemann · Translational Cancer Research · 6
Zinc Deficiency-induced Hypogeusia in a Patient with Refractory Iron-deficiency Anemia: A Case Report
2019 · Alex J Gooding, Clifford D Packer, et al. · Cureus · 5
PDF
Analysis of the zebrafish sox9b promoter: Identification of elements that recapitulate organ-specific expression of sox9b
2015 · Felipe R. Burns, Kevin A. Lanham, et al. · Gene · 4
Works count: 10
Citation count: 382
H-index: 6
I10-index: 6
Year
Topic
Type